- Modular Medical (MODD) intends to deploy the MODD1 on a larger number of clinicians in mid August SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular Medical, Inc. ("Modular Medical" or the ...

- Will introduce first level of its gamified training application developed by Level Ex, developers of the Level One diabetes-management game SAN DIEGO, CA / ACCESS Newswire / August 8, 2025 / Modular ...

SAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity ...

-Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024 -Pre-clinical study to explore use of MODD1 pump as a personalized delivery system for ...

SAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the “Company”) (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity ...

SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...